Evaxion A (EVAX) Invested Capital (2019 - 2025)
Evaxion A (EVAX) reported Invested Capital of $22.6 million for Q4 2025, up 246.52% on a YoY basis from $6.5 million in Q4 2024, and up 12169.57% quarter-over-quarter from $184000.0 in Q2 2025.
Evaxion A (EVAX) Invested Capital (2019 - 2025) Analysis & Trends
Evaxion A has reported Invested Capital for 7 years, with the latest figure at $22.6 million in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 246.52% year-over-year to $22.6 million; the trailing twelve-month figure through Mar 2026 stood at $184000.0 (up 16.46% YoY), and the FY2025 full-year result was $22.6 million, up 246.52% from the prior year.
- Invested Capital for Q4 2025 stood at $22.6 million, up from $184000.0 in the prior quarter.
- The five-year high for Invested Capital was $36.3 million in Q4 2021, with the low at $125000.0 in Q1 2022.
- Historically, Invested Capital has averaged $8.4 million across 5 years, with a median of $3.9 million in 2023.
- Annual changes were most pronounced in 2023 — Invested Capital jumped 3008.8% — and 2024, when it plunged 96.38%.
- Evaxion A's Invested Capital stood at $36.3 million in 2021, then tumbled by 48.45% to $18.7 million in 2022, then tumbled by 79.05% to $3.9 million in 2023, then jumped by 66.24% to $6.5 million in 2024, then soared by 246.52% to $22.6 million in 2025.
- The last three Invested Capital figures came in at $22.6 million (Q4 2025), $184000.0 (Q2 2025), and $6.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 31.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.58 Mn |
| Jun 30, 2025 | 184,000.00 |
| Dec 31, 2024 | 6.52 Mn |
| Jun 30, 2024 | 158,000.00 |
| Dec 31, 2023 | 3.92 Mn |
| Jun 30, 2023 | 4.37 Mn |
| Mar 31, 2023 | 3.89 Mn |
| Dec 31, 2022 | 18.70 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 36.28 Mn |
| Sep 30, 2021 | 159,000.00 |
| Dec 31, 2020 | 7.06 Mn |
| Dec 31, 2019 | 9.40 Mn |